Tudor Investment Corp’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Sell |
55,448
-17,149
| -24% | -$240K | ﹤0.01% | 1179 |
|
|
2025
Q1 | $987K | Buy |
+72,597
| New | +$987K | ﹤0.01% | 1025 |
|
|
2024
Q3 | – | Sell |
-58,523
| Closed | -$1.36M | – | 1680 |
|
|
2024
Q2 | $1.36M | Sell |
58,523
-13,128
| -18% | -$305K | 0.01% | 874 |
|
|
2024
Q1 | $1.47M | Buy |
+71,651
| New | +$1.47M | 0.01% | 776 |
|
|
2023
Q4 | – | Sell |
-42,020
| Closed | -$867K | – | 1586 |
|
|
2023
Q3 | $867K | Buy |
+42,020
| New | +$867K | 0.01% | 953 |
|
|
2023
Q2 | – | Sell |
-55,346
| Closed | -$1.28M | – | 1631 |
|
|
2023
Q1 | $1.28M | Buy |
55,346
+5,415
| +11% | +$125K | 0.02% | 813 |
|
|
2022
Q4 | $1.39M | Buy |
+49,931
| New | +$1.39M | 0.03% | 700 |
|
|
2022
Q3 | – | Sell |
-16,464
| Closed | -$485K | – | 1669 |
|
|
2022
Q2 | $485K | Buy |
+16,464
| New | +$485K | 0.01% | 1086 |
|
|
2021
Q2 | – | Sell |
-39,106
| Closed | -$2.23M | – | 1555 |
|
|
2021
Q1 | $2.23M | Buy |
+39,106
| New | +$2.23M | 0.04% | 464 |
|
|
2020
Q3 | – | Sell |
-37,926
| Closed | -$917K | – | 1329 |
|
|
2020
Q2 | $917K | Buy |
+37,926
| New | +$917K | 0.05% | 497 |
|